Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
Pierre François Laterre, Bruno François, Christine Collienne, Philippe Hantson, Robin Jeannet, Kenneth E. Remy, Richard S. Hotchkiss
Abstract
lymphocytes returning to a reference level, appearing to reverse a pathologic hallmark of COVID-19.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)ImmunotherapyCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyLymphocyteMedicineDiseaseInterleukin 2VirologyImmune systemInternal medicineInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research